Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, First-in-Human, Single Intervention Study for Evaluation of EpiBone-CMF Engineered Living Bone Graft for Mandibular Ramus Reconstruction

NCT03678467 is registered in ClinicalTrials.gov with Epibone, Inc. as lead sponsor.

NCT NCT03678467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03678467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, First-in-Human, Single Intervention Study for Evaluation of EpiBone-CMF Engineered Living Bone Graft for Mandibular Ramus Reconstruction
Lead sponsor
Epibone, Inc.
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 2021
Completion date
November 30, 2023
Enrollment
6 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

mandible tumor, mandible; deformity, mandibular injuries